The knockout of carbohydrate response element-binding protein (ChREBP), a major transcription factor controlling the activation of glucose-induced lipogenesis in the liver of mice, results in hyperlipidemia and hyperinsulinemia and steatosis without inflammation [81]. This evidence concerns the gene MLXIPL and steatosis.